-transparent.png){kind=logo}
3-Hydroxypyridines, which are inhibitors of cyclic nucleotide phosphodiesterase, affected reversibly and non-competitively the enzyme molecule as compared with cAMP. A number of substances was found exhibiting high inhibitory and antioxidant activities, high inhibitory and low antioxidant activities, as well as low inhibitory and high antioxidant activities. Elucidation of the 3-hydroxypyridines action via antioxidant or phosphodiesterase pathways became possible.
Related Publications
N B Polyansky, and
L D Smirnov, and
A A Shvedova, and
V E Kagan, and
V A Tkachuk
November 1979,
Biochemical and biophysical research communications,
N B Polyansky, and
L D Smirnov, and
A A Shvedova, and
V E Kagan, and
V A Tkachuk
May 1972,
Molecular pharmacology,
N B Polyansky, and
L D Smirnov, and
A A Shvedova, and
V E Kagan, and
V A Tkachuk
January 1974,
Methods in enzymology,
N B Polyansky, and
L D Smirnov, and
A A Shvedova, and
V E Kagan, and
V A Tkachuk
June 1989,
Arzneimittel-Forschung,
N B Polyansky, and
L D Smirnov, and
A A Shvedova, and
V E Kagan, and
V A Tkachuk
January 1986,
Ukrainskii biokhimicheskii zhurnal (1978),
N B Polyansky, and
L D Smirnov, and
A A Shvedova, and
V E Kagan, and
V A Tkachuk
October 1988,
Biochemical pharmacology,
N B Polyansky, and
L D Smirnov, and
A A Shvedova, and
V E Kagan, and
V A Tkachuk
December 1985,
Agents and actions,
N B Polyansky, and
L D Smirnov, and
A A Shvedova, and
V E Kagan, and
V A Tkachuk
February 1974,
Life sciences,
N B Polyansky, and
L D Smirnov, and
A A Shvedova, and
V E Kagan, and
V A Tkachuk
September 1982,
Biochemical pharmacology,
N B Polyansky, and
L D Smirnov, and
A A Shvedova, and
V E Kagan, and
V A Tkachuk
January 1975,
Journal of cyclic nucleotide research,
